Re: BETonMACE Placebo Estimate
|
6
|
Resverlogix Corp.
|
Feb 19, 2019 09:45PM
|
Re: European Atherosclerosis Society 2019 meeting May 26-29
|
6
|
Resverlogix Corp.
|
May 27, 2019 05:02PM
|
Re: Not even on the radar in this "state of the art" review
|
6
|
Resverlogix Corp.
|
Jun 20, 2018 02:45PM
|
BET inhibition and liver disease
|
6
|
Resverlogix Corp.
|
Sep 20, 2016 05:19PM
|
Re: time lines and yet to come...
|
6
|
Zenith Epigenetics
|
Aug 16, 2018 10:57AM
|
Re: What Did WE Learn Today
|
6
|
Resverlogix Corp.
|
Dec 15, 2016 05:34PM
|
Re: Last hour.....
|
6
|
Resverlogix Corp.
|
Jun 01, 2019 12:28PM
|
Re: COVID-19 "competition" to keep an eye on.
|
6
|
Resverlogix Corp.
|
Feb 09, 2021 04:28PM
|
Colchicine....strong support of inflammation hypothesis
|
6
|
Resverlogix Corp.
|
Aug 31, 2020 12:28PM
|
A few clarifications from IR
|
6
|
Resverlogix Corp.
|
Mar 01, 2019 05:12PM
|
Re: Gordon Research Conference
|
6
|
Resverlogix Corp.
|
May 30, 2019 09:50AM
|
Re: Riding the Xtandi coat tails
|
6
|
Zenith Epigenetics
|
Jul 16, 2018 10:52AM
|
AHA Abstracts will be posted Monday 11/9 at 4AM CST
|
6
|
Resverlogix Corp.
|
Nov 08, 2020 12:31PM
|
Re: Will we see 5 point MACE reduction results in BETONMACE
|
6
|
Resverlogix Corp.
|
Jun 18, 2019 11:45AM
|
Re: AHA Late Breaker!
|
6
|
Resverlogix Corp.
|
Sep 21, 2019 08:06AM
|
Re: Top 5 things Apabetalone could correct for our health,...
|
6
|
Resverlogix Corp.
|
Nov 11, 2019 12:10PM
|
Re: Not even on the radar in this "state of the art" review
|
6
|
Resverlogix Corp.
|
Jun 20, 2018 03:58PM
|
The final events.....
|
6
|
Resverlogix Corp.
|
Jan 25, 2019 10:48AM
|
Re: The waiting game.....
|
6
|
Resverlogix Corp.
|
Feb 04, 2019 11:34AM
|
Re: Targeting Epigenetics as a New Therapy in Vascular Disease and Dementia
|
6
|
Resverlogix Corp.
|
Aug 29, 2019 02:44PM
|